CAS No. |
63912-02-7 |
中文名称 |
(2S,3S,4S,5R,6R)-6-(2-(((6-(双(2-羟乙基)氨基)-4,8-二(哌啶-1-基)嘧啶并[5,4-d]嘧啶-2-基)(2-羟乙基)氨基)乙氧基))-3,4,5-三羟基四氢-2H-吡喃-2-羧酸 |
英文名称 |
(2S,3S,4S,5R,6R)-6-(2-((6-(Bis(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl)(2-hydroxyethyl)amino)ethoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
别名 |
2-[[6-[Bis(2-Hydroxyethyl)amino]-4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidin-2-yl](2-hydroxyethyl)amino]ethyl b-D-glucopyranosiduronic Acid;Dipyridamole Mono-O-b-D-glucuronide;2-[[6-[Bis(2-Hydroxyethyl)amino]-4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidin-2-yl](2-hydroxyethyl)amino]ethyl -D-glucopyranosiduronic Acid;Dipyridamole Mono-O--D-glucuronide;O1-[2-({6-[bis-(2-hydroxy-ethyl)-amino]-4,8-di-piperidin-1-yl-pyrimido[5,4-d]pyrimidin-2-yl}-(2-hydroxy-ethyl)-amino)-ethyl]-hexopyranuronic acid;β-D-Glucopyranosiduronic acid, 2-[[6-[bis(2-hydroxyethyl)amino]-4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidin-2-yl](2-hydroxyethyl)amino]ethyl;Dipyridamole Mono-O-β-D-glucuronide;Dipyridamole mono-O-Beta-D-glucuronide |
标准英文名 |
(2S,3S,4S,5R,6R)-6-(2-((6-(bis(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl)(2-hydroxyethyl)amino)ethoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
分子式 |
C30H48N8O10 |
分子量 |
680.76
|
精确分子量 |
680.35
|
SMILES |
O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OCCN(C2=NC(N3CCCCC3)=C(N=C(N(CCO)CCO)N=C4N5CCCCC5)C4=N2)CCO |
标准SMILES |
OC(=O)[C@H]1O[C@@H](OCCN(CCO)C2=NC(=C3N=C(N=C(C3=N2)N2CCCCC2)N(CCO)CCO)N2CCCCC2)[C@H](O)[C@@H](O)[C@@H]1O |
用途 |
Dipyridamole Mono-O-β-D-glucuronide (compound M4) is a metabolite of dipyridamole, acting as a phosphodiesterase (PDE) inhibitor and a breast cancer resistance protein (BCRP) inhibitor; it is an O-glucuronide conjugate. |
InChIKey |
UINLJWRYFLLHGA-KGRBZTTASA-N |